2型糖尿病合并新型冠状病毒奥密克戎变异株感染轻症患者出院时的中医症状特征及荆银固表方干预疗效
Characteristics of traditional Chinese medicine symptoms in patients of mild novel coronavirus omicron variant infection combined with type 2 diabetes mellitus when discharged from the hospital and the intervention effect of Jingyin Gubiao Formula
- 上海中医药大学学报 2023年37卷第2期 页码：28-34
- 作者机构：
1.上海中医药大学附属曙光医院（上海 201203）
- 作者简介：
陶乐维，男，博士，副主任医师，主要从事糖尿病及其慢性并发症的临床与基础研究
陈麒，主任医师，硕士生导师；E-mail： chenqiywl@126.com
郝微微，主任医师，硕士生导师；E-mail： hwwwork@163.com
- 基金信息：上海市卫健委中医药防治新冠肺炎科研攻关项目(XGYJKY2022-06);上海中医药大学应对奥密克戎感染新型冠状病毒肺炎应急科研攻关项目(2022YJ-24);上海市临床重点专科（中医内分泌科）建设项目(shslczdzk05401);上海市中医临床重点实验室项目(20DZ2272200);上海市进一步加快中医药传承创新发展三年行动计划项目［ZY（2021-2023）-0302］;上海市进一步加快中医药事业发展三年行动计划中医糖尿病专科联盟建设项目［ZY（2018-2020）-FWTX-4011］
DOI：10.16306/j.1008-861x.2023.02.005
中图分类号：
扫 描 看 全 文
陶乐维,张一乐,陆灏等.2型糖尿病合并新型冠状病毒奥密克戎变异株感染轻症患者出院时的中医症状特征及荆银固表方干预疗效[J].上海中医药大学学报,2023,37(02):28-34.
TAO Lewei,ZHANG Yile,LU Hao,et al.Characteristics of traditional Chinese medicine symptoms in patients of mild novel coronavirus omicron variant infection combined with type 2 diabetes mellitus when discharged from the hospital and the intervention effect of Jingyin Gubiao Formula[J].Academic Journal of Shanghai University of Traditional Chinese Medicine,2023,37(02):28-34.
陶乐维,张一乐,陆灏等.2型糖尿病合并新型冠状病毒奥密克戎变异株感染轻症患者出院时的中医症状特征及荆银固表方干预疗效[J].上海中医药大学学报,2023,37(02):28-34. DOI： 10.16306/j.1008-861x.2023.02.005.
TAO Lewei,ZHANG Yile,LU Hao,et al.Characteristics of traditional Chinese medicine symptoms in patients of mild novel coronavirus omicron variant infection combined with type 2 diabetes mellitus when discharged from the hospital and the intervention effect of Jingyin Gubiao Formula[J].Academic Journal of Shanghai University of Traditional Chinese Medicine,2023,37(02):28-34. DOI： 10.16306/j.1008-861x.2023.02.005.
摘要
目的,2,对符合出院标准的2型糖尿病合并新型冠状病毒奥密克戎变异株感染轻症患者的中医症状特征进行分析，并观察荆银固表方的干预作用。,方法,2,将出院时符合标准的790例新型冠状病毒肺炎患者按1∶1比例随机分为治疗组和对照组，每组各395例。治疗组中符合2型糖尿病诊断标准的146例患者为糖尿病治疗组，其余249例患者为非糖尿病治疗组；对照组中符合2型糖尿病诊断标准的129例患者为糖尿病对照组，其余266例患者为非糖尿病对照组。出院时，治疗组患者给予荆银固表方口服，疗程为1周；对照组患者不发放药物。比较糖尿病治疗组和非糖尿病治疗组患者出院时的中医症状评分；比较糖尿病对照组及糖尿病治疗组患者于荆银固表方治疗前后的中医症状评分。组间比较时，如基线数据不均衡，将有差异的指标作为协变量进行倾向性得分匹配，获得组间均衡的数据后再进行组间中医症状评分比较。,结果,2,①出院时，除喘息症状外，非糖尿病治疗组患者的中医症状较糖尿病治疗组均较轻（,P,<,0.01，,P,<,0.05）。②治疗后，糖尿病治疗组患者的各项中医症状较治疗前均明显改善（,P,<,0.01，,P,<,0.05），糖尿病对照组患者的恶寒、汗出、头痛、咳嗽、咽痛症状较治疗前亦明显改善（,P,<,0.01，,P,<,0.05），且糖尿病治疗组患者的恶寒、汗出、咳嗽、咯痰症状的改善优于糖尿病对照组（,P,<,0.01，,P,<,0.05）。,结论,2,与非糖尿病患者相比，合并2型糖尿病的新型冠状病毒奥密克戎变异株感染轻症患者即使在符合出院条件时仍存在较严重的肺系症状，荆银固表方对改善这些症状具有一定的作用。
Abstract
Objective： To analyze the characteristics of traditional Chinese medicine （TCM） symptoms in patients of mild novel coronavirus omicron variant infection combined with type 2 diabetes mellitus who met the discharge criteria and observe the intervention effect of Jingyin Gubiao Formula.,Methods,2,A total of 790 patients with corona virus disease 2019 （COVID-19） who met the criteria when discharged from the hospital were randomly divided into the treatment group and the control group at a ratio of 1∶1， 395 cases in each group. In the treatment group， 146 patients who met the diagnostic criteria of type 2 diabetes mellitus were enrolled in the diabetic treatment group， and the other 249 patients were enrolled in the non-diabetic treatment group. In the control group， 129 patients who met the diagnostic criteria of type 2 diabetes mellitus were enrolled in the diabetic control group， and the other 266 patients were enrolled in the non-diabetic control group. When discharged from the hospital， the patients in the treatment group were given Jingyin Gubiao Formula orally with a course of 1 week， while the patients in the control group were not given any medicine. The TCM symptom scores of the patients when discharged from the hospital were compared between the diabetic treatment group and the non-diabetic treatment group. Before and after treatment of Jingyin Gubiao Decoction ， the TCM symptom scores were compared between the diabetic treatment group and the diabetic control group. If the baseline data were not balanced between the two groups， the indicators with differences were taken as the covariates to perform the propensity score matching in order to obtain the balanced data between the two groups， and then the TCM symptom scores were compared between the two groups.,Results,2,①When the patients were discharged from the hospital， except for wheezing symptom， the other TCM symptoms in the non-diabetic treatment group were milder than those in the diabetic treatment group （,P,<,0.01， ,P,<,0.05）. ②After treatment， all the TCM symptoms in the diabetic treatment group were significantly improved compared with those before treatment （,P,<,0.01， ,P,<,0.05）， the symptoms including aversion to cold， sweating， headache， cough and sore throat in the diabetic control group were also significantly improved compared with those before treatment （,P,<,0.01， ,P,<,0.05）， and the improvement of the symptoms including aversion to cold， sweating， cough and expectoration in the diabetic treatment group were better than those in the diabetic control group （,P,<,0.01， ,P,<,0.05）.,Conclusion,2,Compared with the non-diabetic patients， the patients of mild novel coronavirus omicron variant infection combined with type 2 diabetes mellitus still have more severe pulmonary symptoms even when they met the discharge criteria， and Jingyin Gubiao Formula has a certain effect on improving these symptoms.
关键词
2型糖尿病新型冠状病毒肺炎奥密克戎变异株中医症状荆银固表方上海
Keywords
type 2 diabetes mellitusCOVID-19omicron varianttraditional Chinese medicine symptomsJingyin Gubiao FormulaShanghai
references
王卫庆， 刘建民， 张翼飞， 等. 新型冠状病毒肺炎疫情下糖尿病管理专家建议［J］. 诊断学理论与实践， 2022， 21（2）： 136-138.
WANG W Q， LIU J M， ZHANG Y F， et al. Expert suggestion for diabetes management during the recent COVID-19 pandemic［J］. Journal of Diagnostics Concepts & Practice， 2022， 21（2）： 136-138.
赵勇， 谢敏， 李会敏， 等. 2型糖尿病合并新型冠状病毒肺炎患者的临床特征及中医病机分析［J］. 湖北中医药大学学报， 2020， 22（4）： 100-104.
ZHAO Y， XIE M， LI H M， et al. Clinical Characteristics and Pathogenesis of Traditional Chinese Medicine in Patients with Type 2 Diabetes Mellitus Combined with Novel Coronavirus Pneumonia［J］. Journal of Hubei University of Chinese Medicine， 2020， 22（4）： 100-104.
陈博武， 杨梦琪， 温宗麟， 等. 上海地区新型冠状病毒奥密克戎变异株感染轻症患者中医证候特征研究［J］. 中医杂志， 2022， 63（15）： 1436-1441.
CHEN B W， YANG M Q， WEN Z L， et al. Characteristics of Traditional Chinese Medicine Syndromes in Mild COVID-19 Cases of Omicron Variant in Shanghai［J］. Journal of Traditional Chinese Medicine， 2022， 63（15）： 1436-1441.
ZHANG X， ZHANG W， CHEN S. Shanghai’s life-saving efforts against the current omicron wave of the COVID-19 pandemic［J］. Lancet， 2022， 399（10340）： 2011-2012.
中国国家卫生健康委员会. 新型冠状病毒肺炎诊疗方案（试行第九版）［J］. 国际流行病学传染病学杂志， 2022， 49（2）： 73-80.
National Health Commission of People’s Republic of China. Diagnosis and treatment plan for COVID-19 （trial version 9）［J］. International Journal of Epidemiology and Infectious Disease， 2022， 49（2）： 73-80.
中华医学会糖尿病学分会. 中国2型糖尿病防治指南（2020年版）［J］. 中华糖尿病杂志， 2021， 13（4）： 315-409.
Diabetes Society of Chinese Medical Association. Guideline for the prevention and treatment of type 2 diabetes mellitus in China （2020 edition）［J］. Chinese Journal of Diabetes， 2021， 13（4）： 315-409.
郑筱萸. 中药新药临床研究指导原则（试行）［M］. 北京： 中国医药科技出版社， 2002.
ZHENG X Y. Guidelines for Clinical Research of New Chinese Medicine （Trial）［M］. Beijing： China Medical Science and Technology Press， 2002.
王阳春， 仝瑞祥， 刘飞， 等. 糖尿病患者易感新型冠状病毒的免疫因素分析［J］. 中国糖尿病杂志， 2020， 28（3）： 176-179.
WANG Y C， TONG R X， LIU F， et al. Analysis of the immune risk factors for COVID-19 infection in patients with diabetes［J］. Chinese Journal of Diabetes， 2020， 28（3）： 176-179.
王之旸， 何君， 程杨阳， 等. 2型糖尿病患者感染新型冠状病毒肺炎的临床特征及转归［J］. 中华内分泌代谢杂志， 2020， 36（8）： 654-660.
WANG Z Y， HE J， CHENG Y Y， et al. Clinical characteristics and outcomes of COVID-19 infected patients with type 2 diabetes mellitus［J］. Chinese Journal of Endocrinology and Metabolism， 2020， 36（8）： 654-660.
ONDER G， REZZA G， BRUSAFERRO S. Case-Fatality Rate and Characteristics of Patients Dying in Relation to COVID-19 in Italy［J］. JAMA， 2020， 323（18）： 1775-1776.
MCGURNAGHAN S J， WEIR A， BISHOP J， et al. Risks of and risk factors for COVID-19 disease in people with diabetes： a cohort study of the total population of Scotland［J］. Lancet Diabetes Endocrinol， 2021， 9（2）： 82-93.
BARRON E， BAKHAI C， KAR P， et al. Associations of type 1 and type 2 diabetes with COVID-19-related mortality in England： a whole-population study［J］. Lancet Diabetes Endocrinol， 2020， 8（10）： 813-822.
YONEKAWA A， SHIMONO N. Clinical Significance of COVID-19 and Diabetes： In the Pandemic Situation of SARS-CoV-2 Variants including Omicron （B.1.1.529）［J］. Biology （Basel）， 2022， 11（3）： 400.
吕卓瑶， 王浩， 庞先琼， 等. 新冠疫情对COPD患者病情控制及心理状态的影响［J］. 中华肺部疾病杂志（电子版）， 2021， 14（2）： 189-194.
LYU Z Y， WANG H， PANG X Q， et al. Impact of COVID-19 on COPD patients’ symptom control and mental health［J］.Chinese Journal of Lung Diseases （Electronic Edition）， 2021， 14（2）： 189-194.
傅燚， 孙跃喜， 张宸韬， 等. 上海市方舱医院新型冠状病毒肺炎患者心理健康状况调查及影响因素研究［J］. 同济大学学报（医学版）， 2022， 43（3）： 303-309.
FU Y， SUN Y X， ZHANG C T， et al. A survey of mental health and influencing factors of COVID-19 patients in fangcang shelter hospitals in Shanghai［J］. Journal of Tongji University （Medical Science）， 2022， 43（3）： 303-309.
章诚杰， 姚轶立， 周丹， 等. 干姜小柴胡汤治疗新型冠状病毒奥密克戎变异株感染轻型患者的临床观察［J］. 上海中医药杂志， 2022， 56（9）： 1-4.
ZHANG C J， YAO Y L， ZHOU D， et al. Clinical observation on Ganjiang Xiaochaihu Decoction in treating patients with mild infection of COVID⁃19 Omicron variant［J］. Shanghai Journal of Traditional Chinese Medicine， 2022， 56（9）： 1-4.
刘清泉， 夏文广， 安长青， 等. 中西医结合治疗新型冠状病毒肺炎作用的思考［J］. 中医杂志， 2020， 61（6）： 463-464.
LIU Q Q， XIA W G， AN C Q， et al. Refection on Effects of Integrated Traditional Chinese and Western Medicine on Coronavirus Disease［J］. Journal of Traditional Chinese Medicine， 2020， 61（6）： 463-464.
杨丰文， 张俊华， 胡鸿毅， 等. 上海市新型冠状病毒肺炎重症患者中西医结合救治策略与经验［J］. 上海中医药杂志， 2022， 56（7）： 1-4.
YANG F W， ZHANG J H， HU H Y， et al. Treatment strategies and experience of integrated traditional Chinese and western medicine for severe COVID⁃19 patients in Shanghai［J］. Shanghai Journal of Traditional Chinese Medicine， 2022， 56（7）： 1-4.
上海市新型冠状病毒感染恢复期中医康复方案专家共识撰写组. 上海市新型冠状病毒感染恢复期中医康复方案专家共识（2022年第2版）［J］. 上海中医药杂志， 2022， 56（8）： 1-3.
Writing Group of Expert Consensus on Traditional Chinese Medicine Rehabilitation Protocol in COVID-19 Recovery Period in Shanghai. Expert consensus on traditional Chinese medicine rehabilitation protocol in COVID-19 recovery period in Shanghai （2nd edition， 2022）［J］. Shanghai Journal of Traditional Chinese Medicine， 2022， 56（8）： 1-3.
0
浏览量
222
下载量
0
CSCD
0
CNKI被引量
- 网络PDF下载
- BibTeX下载
- Endnote下载
- RefMan 下载
- NoteExpress下载
- NoteFirst下载
关联资源
相关文章
相关作者
相关机构
- 技术支持由北京北大方正电子有限公司提供 京ICP备09064830号-19
京公网安备11010802024621 - 本系统建议在Chrome、 IE9+ 以上版本浏览器阅读本站内容，360浏览器请切换至极速模式
- Cookies帮助我们提供服务并提供个性化体验。使用本网站，即表示您同意我们使用Cookies
- 总访问量：10154 今日访问量：17